Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Vivo Opportunity, LLC is named as a reporting person in SEC Form 4 filings. OQRO lists 30 transactions filed with the SEC under this name, the latest on Jul 17, 2026, each linked to the official Form 4.
Disclosures on record
30
Companies involved
1
3 buys, median −15.4 pts vs S&P 500, beat it 0 of 3 times.
Average −16.5 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Jun 11, 2026 to Jul 17, 2026, measured from the first close after the filing. Past results, not a forecast.
Inmed PharmaceuticalsINM
30 disclosures · Jun 2026 – Jul 2026 · 30 bought
Jul 15, 2026Bought~$21Kdisclosed Jul 17
DetailsOfficial recordJul 14, 2026Bought~$764disclosed Jul 17
DetailsAs of the latest filing on , Vivo Opportunity, LLC reported holding 818,076 shares of Inmed Pharmaceuticals (INM), worth about $12.7M at the last close of $16 (Nov 13, 2026), held through a vivo opportunity cayman fund, l.p, a vivo opportunity fund holdings, l.p. In the last 12 months, Vivo Opportunity, LLC bought $434K in 30 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Inmed Pharmaceuticals INM | 818,076 | 75K vivo opportunity cayman fund, l.p · 743K vivo opportunity fund holdings, l.p | $16 | $12.7M | Jul 16, 2026 |
Is this Vivo Opportunity, LLC’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Jul 15, 2026Bought~$2.2Kdisclosed Jul 17
DetailsOfficial recordJul 16, 2026Bought~$29disclosed Jul 17
DetailsOfficial recordJul 16, 2026Bought~$3disclosed Jul 17
DetailsOfficial recordJul 14, 2026Bought~$7.6Kdisclosed Jul 17
DetailsOfficial recordJul 2, 2026Bought~$228disclosed Jul 3
DetailsOfficial recordJun 30, 2026Bought~$839disclosed Jul 3
DetailsOfficial recordJun 30, 2026Bought~$85disclosed Jul 3
DetailsOfficial recordJul 1, 2026Bought~$6.1Kdisclosed Jul 3
DetailsOfficial recordJul 1, 2026Bought~$617disclosed Jul 3
DetailsOfficial recordJul 2, 2026Bought~$2.3Kdisclosed Jul 3
DetailsOfficial recordJun 5, 2026Bought~$78Kdisclosed Jun 11
DetailsOfficial recordMay 20, 2026Bought~$80Kdisclosed Jun 11
DetailsOfficial recordMay 21, 2026Bought~$52Kdisclosed Jun 11
DetailsOfficial recordJun 8, 2026Bought~$45Kdisclosed Jun 11
DetailsOfficial recordJun 2, 2026Bought~$32Kdisclosed Jun 11
DetailsOfficial recordMay 29, 2026Bought~$25Kdisclosed Jun 11
DetailsOfficial recordJun 1, 2026Bought~$23Kdisclosed Jun 11
DetailsOfficial recordJun 3, 2026Bought~$11Kdisclosed Jun 11
DetailsOfficial recordJun 4, 2026Bought~$970disclosed Jun 11
DetailsOfficial recordJun 5, 2026Bought~$7.9Kdisclosed Jun 11
DetailsOfficial recordJun 8, 2026Bought~$4.5Kdisclosed Jun 11
DetailsOfficial recordMay 20, 2026Bought~$8Kdisclosed Jun 11
DetailsOfficial recordMay 21, 2026Bought~$5.3Kdisclosed Jun 11
DetailsOfficial recordMay 29, 2026Bought~$2.6Kdisclosed Jun 11
DetailsOfficial recordJun 1, 2026Bought~$2.3Kdisclosed Jun 11
DetailsOfficial recordJun 2, 2026Bought~$3.2Kdisclosed Jun 11
DetailsOfficial recordJun 3, 2026Bought~$1.1Kdisclosed Jun 11
DetailsOfficial recordJun 4, 2026Bought~$9.6Kdisclosed Jun 11
DetailsOfficial recordVivo Opportunity, LLC bought shares on the open market in 2026.
Vivo Opportunity, LLC reported 30 open-market purchases and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $434K30×30 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jul 16, 2026, Vivo Opportunity, LLC reported holding 818,076 shares of Inmed Pharmaceuticals (INM), held indirectly. At the last close of $16 on Nov 13, 2026, that is about $12.7M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Vivo Opportunity, LLC reported 30 open-market purchases worth $434K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Vivo Opportunity, LLC bought shares on the open market in 2026.
In SEC filings since 2026: the latest open-market purchase is from 2026; no open-market sale is on record.
Inmed Pharmaceuticals (INM), from 2026 to 2026: 30 purchases and 0 sales.
Vivo Opportunity, LLC reported 30 open-market purchases and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
